Latest News for: transcode

Edit

Preliminary Proxy Statement (Form PRE 14A) (Transcode Therapeutics Inc)

Public Technologies 02 Apr 2025
TransCode Therapeutics, Inc ... TRANSCODE THERAPEUTICS, INC ... References in this Proxy Statement to "we," "us," "our," the "Company" or "TransCode" refer to TransCode Therapeutics, Inc.
Edit

Late Filing Notice (Form NT 10-K) (Transcode Therapeutics Inc)

Public Technologies 31 Mar 2025
TransCode Therapeutics, Inc ... TransCode Therapeutics, Inc, (the "Company") has determined that it will not be able to file its Annual ... TransCode Therapeutics, Inc ... Transcode Therapeutics Inc.
Edit

TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Form 8-K) (Transcode Therapeutics Inc)

Public Technologies 25 Mar 2025
TransCode Therapeutics, Inc ... BOSTON, March 23, 2025 - TransCode Therapeutics, Inc ... About TransCode Therapeutics, Inc. TransCode is a clinical-stage oncology company focused on treating metastatic disease ... TransCode Therapeutics, Inc.
Edit

Supplemental Prospectus (Form 424B5) (Transcode Therapeutics Inc)

Public Technologies 25 Mar 2025
TransCode Therapeutics, Inc ... For the purpose of this prospectus supplement and the accompanying prospectus, TransCode Therapeutics® is referred to as TransCode ... On October 20, 2021, TransCode Therapeutics, Inc ... TransCode Therapeutics, Inc.
  • 1
×